Not Tagged
Not Tagged
['rectal']
neoadjuvant folfox vs. chemoxrt in rectal cancer? complicated study. not everyone in chemoxrt arm went on to get adjuvant folfox. 10% of pts in neo folfox got chemoxrt. food for thought but will it change soc? #asco23 
Jeff Yorio, MD is a practicing medical oncologist and hematologist at Texas Oncology in Austin, Texas.  He is actively involved in clinical trials in Austin.